Search Results for: Oral Delivery of Peptides by
Articles
April 30, 2013
FORMULATION DEVELOPMENT - Trends & Opportunities in Particle Design Technologies - Life Sciences & Biopharma in the Spotlight April 30, 2013
Frost & Sullivan Analyst, Cecilia Van Cauwenberghe, MS, examines the observed trends in particle design and engineering technologies, as well as the main factors and opportunities driving the principal technological advances in the biopharmaceutical industry.
March 13, 2013
FORMULATION DEVELOPMENT - Bioavailability Enhancement Strategies & Opportunities March 13, 2013
Frost & Sullivan Analyst Ruplekha Choudhurie reviews some BA approaches that are being developed by a number of companies that can mitigate the biological, physical, and chemical barriers for effective delivery of poorly soluble and permeable drugs.
November 19, 2012
11/21/2012 November 19, 2012
Innovative Drugs to Transform Alzheimer's Disease Medication Market The patent expiry of all four existing EMEA-approved drugs for Alzheimer's disease...
October 7, 2012
10/10/2012 October 7, 2012
Cleveland BioLabs & Incuron Announce Orphan Drug Status Cleveland BioLabs, Inc. and Incuron, LLC, a joint venture between the company...
October 7, 2012
4P Therapeutics Announces Major Development Partnership October 7, 2012
4P Therapeutics, a drug delivery company with expertise in novel drug delivery technologies, recently announced a partnership with Medicure Inc....
July 30, 2012
8/1/2012 July 30, 2012
BD Launches Thin-Wall Needle Technology BD Medical recently announced the launch of the BD Hyflow needle, a unique 27-gauge thin-wall...
June 18, 2012
6/20/2012 June 18, 2012
Astex Earns $5.4-Million Milestone Astex Pharmaceuticals, Inc. recently announced that Janssen Pharmaceutica NV has received clearance to commence a Phase...
May 20, 2012
5/23/2012 May 20, 2012
Agilent to Acquire Cancer Diagnostic Company for $2.2 Billion Agilent Technologies Inc. and EQT, the Sweden-based private equity group, recently...
May 6, 2012
5/9/2012 May 6, 2012
Caisson Biotech Enters Potential $100 Million Agreement Caisson Biotech, L.L.C. recently announced it has entered into a development and license...
February 5, 2012
2/7/2012 February 5, 2012
Foster Analytical Services Speed Time to Market for Drug Delivery Formulations Foster Delivery Science, a business unit for Foster Corporation,...
December 18, 2011
12/20/2011 December 18, 2011
Enlight Biosciences Forms Lucrative New Partnerships Enlight Biosciences LLC recently announced today it has formed new partnerships with AstraZeneca and...
December 18, 2011
Enlight Biosciences Forms Lucrative New Partnerships December 18, 2011
Enlight Biosciences LLC recently announced today it has formed new partnerships with AstraZeneca and Novo Nordisk. As partners in Enlight,...
November 27, 2011
11/29/2011 November 27, 2011
Biocon Launches Haselmeier's Insulin Pen in India Haselmeier recently announced that Biocon, one of Asia's premier biotechnology companies, has launched...
November 20, 2011
11/22/2011 November 20, 2011
Apricus Biosciences Announces NexACT Partner Has Completed pre-IND Meeting Apricus Biosciences, Inc. recently announced its NexACT out-licensing partner, Exodos Life...
November 20, 2011
MonoSol Rx & Midatech Ltd Receive Authorization to Conduct Phase I Human Trials November 20, 2011
MonoSol Rx, the developer of PharmFilm drug delivery technology, and its collaboration partner Midatech Ltd., a global leader and centre...
October 13, 2011
10/17/2011 October 13, 2011
Oncobiologics Announces Two New Agreements Worth Almost $80 Million Oncobiologics recently announced it has signed two major agreements. The first...
October 9, 2011
10/11/2011 October 9, 2011
Carticept Medical Receives 510(k) Clearance for Navigator Delivery System Carticept Medical, Inc., a developer of innovative products for the treatment...
September 27, 2011
10/4/2011 September 27, 2011
Talon Therapeutics' NDA Accepted for Filing by US FDA Under Subpart H Talon Therapeutics, Inc. recently announced its NDA seeking...
September 1, 2011
9/6/2011 September 1, 2011
Jennerex's Virus-Based Drug Targets & Infects Tumors Jennerex, Inc. recently announced the publication of clinical data on its lead product...
August 18, 2011
8/23/2011 August 18, 2011
Intellipharmaceutics & Par Pharmaceutical Expand Development & Commercialization Agreement Intellipharmaceutics International Inc. recently announced that they have added the development...
August 31, 2022
WHITEPAPER - Key Considerations in Oral Delivery of Peptides – Factors to Consider While Evaluating Oral Administration
Peptide therapeutics are a hot topic in pharmaceutical R&D. While most peptides are administered parenterally, oral delivery of peptide therapeutics...
April 13, 2021
Where Do We Stand on Poorly Soluble Drugs and Peptides in Oral Delivery?
The Rule of 5 suggests that, for oral bioavailability, a better chance for oral absorption is obtained when the molecules are within the parameters of the Rule of 5’. However, the pharmaceutical industry is achieving oral efficacy with drugs that exceed….
August 31, 2023
WHITEPAPER - Accelerate Preclinical Developments & Improve Oral Bioavailability With Lipid-Based Formulation & Encapsulation Technology Combination
This paper covers the benefits of the LBF and capsules combination in dosage form developments, an efficient technology platform to bring efficient and differentiated products to the market.
May 4, 2022
WHITEPAPER: Optimizing Oral Drug Delivery Using Zydis® Orally Disintegrating Tablet Technology to Address Patient Challenges
Many patients prefer conventional tablets for the administration of medications, but some geriatric and pediatric patients and those with altered...
